CannaPharmaRx Inc
OTC:CPMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CannaPharmaRx Inc
OTC:CPMD
|
CA |
|
Sensus Healthcare Inc
NASDAQ:SRTS
|
US |
|
Ravindra Energy Ltd
BSE:504341
|
IN |
|
N
|
Nusantara Inti Corpora Tbk PT
IDX:UNIT
|
ID |
|
Bluestone Jewellery and Lifestyle Ltd
NSE:BLUESTONE
|
IN |
|
Digital Locations Inc
OTC:DLOC
|
US |
|
N
|
NSW Inc
TSE:9739
|
JP |
|
Bain Capital Specialty Finance Inc
NYSE:BCSF
|
US |
|
B
|
BH Co Ltd
KRX:090460
|
KR |
|
C
|
Cleveland-Cliffs Inc
F:CVA
|
US |
|
N
|
Narrowstep Inc
OTC:NRWS
|
US |
|
M
|
MillerKnoll Inc
NASDAQ:MLKN
|
US |
|
G
|
Gulf Development PCL
SET:GULF
|
TH |
|
T
|
TWOSTONE&Sons Inc
TSE:7352
|
JP |
|
S
|
Sunrun Inc
DUS:3S9
|
US |
|
Virbac SA
PAR:VIRP
|
FR |
Bankruptcy Probability
CannaPharmaRx Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CannaPharmaRx Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
CannaPharmaRx Inc
OTC:CPMD
|
1.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
363.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
356.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
192.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
284.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CannaPharmaRx Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CannaPharmaRx Inc has total debt of 1.8m USD. This includes both short-term (1.4m USD) and long-term (335.1k USD) debt.
You can find a full breakdown on its Balance Sheet.